Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3691)
All Articles published online
|
Nov 28, 2005 (publication date) through Feb 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Müller S, Styner M, Seibold-Schmid B, Flogerzi B, Mähler M, Konrad A, Seibold F. Anti- |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i44/6988.htm |
| Number | Citing Articles |
| 1 |
D. А. Kuznetsova, S. V. Lapin, O. B. Shchukina. The diagnostic and prognostic value of serological markers of inflammatory bowel diseases (a literature review). Almanac of Clinical Medicine 2020; 48(6): 364 doi: 10.18786/2072-0505-2020-48-061
|
| 2 |
Iam van Thiel, Wj de Jonge, Rm van den Wijngaard. Fungal feelings in the irritable bowel syndrome: the intestinal mycobiome and abdominal pain. Gut Microbes 2023; 15(1) doi: 10.1080/19490976.2023.2168992
|
| 3 |
Samir Jawhara, Xavier Thuru, Annie Standaert‐Vitse, Thierry Jouault, Serge Mordon, Boualem Sendid, Pierre Desreumaux, Daniel Poulain. Colonization of Mice byCandida albicansIs Promoted by Chemically Induced Colitis and Augments Inflammatory Responses through Galectin‐3. The Journal of Infectious Diseases 2008; 197(7): 972 doi: 10.1086/528990
|
| 4 |
Lani Prideaux, Peter De Cruz, Siew C. Ng, Michael A. Kamm. Serological Antibodies in Inflammatory Bowel Disease: A Systematic Review. Inflammatory Bowel Diseases 2012; 18(7): 1340 doi: 10.1002/ibd.21903
|
| 5 |
Shira Benor, George H. Russell, Michael Silver, Esther J. Israel, Qian Yuan, Harland S. Winter. Shortcomings of the Inflammatory Bowel Disease Serology 7 Panel. Pediatrics 2010; 125(6): 1230 doi: 10.1542/peds.2009-1936
|
| 6 |
A. Eser, P. Papay, C. Primas, E. Pernicka, M. Harrer, C. Dejaco, G. Novacek, C. Lichtenberger, S. Angelberger, L. Kazemi, A. Mikulits, H. Vogelsang, W. Reinisch. The impact of intestinal resection on serum levels of anti‐Saccharomyces cerevisiae antibodies (ASCA) in patients with Crohn’s disease. Alimentary Pharmacology & Therapeutics 2012; 35(2): 292 doi: 10.1111/j.1365-2036.2011.04932.x
|
| 7 |
Thomas Schaffer, Stefan Müller, Beatrice Flogerzi, Beatrice Seibold-Schmid, Alain M. Schoepfer, Frank Seibold. Anti-Saccharomyces cerevisiae mannan antibodies (ASCA) of Crohnʼs patients crossreact with mannan from other yeast strains, and murine ASCA IgM can be experimentally induced with Candida albicans. Inflammatory Bowel Diseases 2007; 13(11): 1339 doi: 10.1002/ibd.20228
|
| 8 |
Ole Høie, Geir Aamodt, Severine Vermeire, Tomm Bernklev, Selwyn Odes, Frank L. Wolters, Lene Riis, Patrizia Politi, Epameinondas V. Tsianos, Mercedes Butrón, Reinhold W. Stockbrügger, Pia Munkholm, Morten Vatn, Bjørn Moum. Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years. Journal of Crohn's and Colitis 2008; 2(2): 114 doi: 10.1016/j.crohns.2007.10.001
|
| 9 |
Annie Standaert-Vitse, Boualem Sendid, Marie Joossens, Nadine François, Peggy Vandewalle-El Khoury, Julien Branche, Herbert Van Kruiningen, Thierry Jouault, Paul Rutgeerts, Corinne Gower-Rousseau, Christian Libersa, Christel Neut, Franck Broly, Mathias Chamaillard, Séverine Vermeire, Daniel Poulain, Jean-Frédéric Colombel. Candida albicans Colonization and ASCA in Familial Crohn's Disease. The American Journal of Gastroenterology 2009; 104(7): 1745 doi: 10.1038/ajg.2009.225
|
| 10 |
C. A. Siegel, H. Horton, L. S. Siegel, K. D. Thompson, T. Mackenzie, S. K. Stewart, P. W. Rice, J. M. Stempak, S. Dezfoli, T. Haritunians, A. Levy, M. Baek, R. Milgrom, P. S. Dulai, S. R. Targan, M. S. Silverberg, M. C. Dubinsky, D. P. McGovern. A validated web‐based tool to display individualised Crohn's disease predicted outcomes based on clinical, serologic and genetic variables. Alimentary Pharmacology & Therapeutics 2016; 43(2): 262 doi: 10.1111/apt.13460
|
| 11 |
Reinhold Ramoner, Andrea Rahm, Hubert Gander, Björn Stollenwerk, Claudia Falkensammer, Nicolai Leonhartsberger, Martin Thurnher. Serum antibodies against Saccharomyces cerevisiae: a new prognostic indicator in metastatic renal-cell carcinoma. Cancer Immunology, Immunotherapy 2008; 57(8): 1207 doi: 10.1007/s00262-008-0454-0
|
| 12 |
C. N. Bernstein, J. D. Ryan, L. A. Graff, W. Xu. Commentary: predicting complicated Crohn's disease and surgery - phenotypes, genetics, serology and psychological characteristics of a population-based cohort - authors’ reply. Alimentary Pharmacology & Therapeutics 2013; 38(5): 556 doi: 10.1111/apt.12423
|
| 13 |
Radislav Nakov, Violeta Snegarova, Desislava Dimitrova-Yurukova, Tsvetelina Velikova. Biomarkers in Irritable Bowel Syndrome: Biological Rationale and Diagnostic Value. Digestive Diseases 2022; 40(1): 23 doi: 10.1159/000516027
|